Health Condition 1: B354- Tinea corporis
Conditions
Interventions
Intervention1: Marham-i Hina: Marham-i Hina(Ointment) for Topical application on affected area for 20 minutes
Control Intervention1: Luliconazole 1%: Topical application of ointment Luliconazole 1% on
Sponsors
Luqman Unani Medical College Hospital and Research Center
Eligibility
Inclusion criteria
Inclusion criteria: 1. Clinically as well as KOH diagnosed cases of tinea corporis without nail and scalp involvement 2. BSA � 20%
Exclusion criteria
Exclusion criteria: 1. Patients those having treatment history of less than 30 days in case of topical antifungal agent, less than 8 weeks in case of systemic antifungals, and less than 30 days in case of systemic corticosteroids. 2. Pregnant and lactating women. 3. Patients with diabetes mellitus. 4. Patients with known skin allergy. 5. Patients with immunosuppressive disease/drugs. 6. Known cases of any serious illness. 7. Superimposed cases of tinea corporis. 8. Non ââ?¬â??compliance to the trial protocol.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| 1. Change in TCS (Total clinical score) 2. Change in Dermatology Life Quality IndexTimepoint: At baseline, 14th day, 28th day and after the Completion of study | — |
Primary
| Measure | Time frame |
|---|---|
| 1. Investigatorsââ?¬â?¢ global assessment (IGA) of clinical responses. 2. Mycological cure: Clinically suspected cases of tinea corporis will be confirmed by skin scraping and KOH preparation, by visualizing long, narrow, septate and branching hyphae under microscope.Timepoint: 1. Before and after the treatment(6th week) | — |
Countries
India
Contacts
Public ContactMeenu Doni
Luqman Unani Medical College Hospital and Research Center Vijayapura
Outcome results
None listed